MedTrace Logo

Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects

NCT01343732 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-07-14

No results posted yet for this study

Summary

The purpose of this study is to test whether the combination of deep transcranial magnetic stimulation (DTMS) treatment with customary medication for obsessive compulsive disorder (OCD) patients is effective than treatment that include only medication.

Conditions

  • Obsessive Compulsive Disorder

Interventions

DEVICE

Deep TMS

deep transcranial magnetic stimulation

Sponsors & Collaborators

  • Brainsway

    lead INDUSTRY

Principal Investigators

  • Yossef Zohar, Prof. · Sheba Medical Center, ramat-gan, Israel

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01343732 on ClinicalTrials.gov